The US FDA has granted a De Novo Classification for the Biolinq Shine, a novel real-time glucose sensor for people with type 2 diabetes (T2D) not on insulin. The new classification allows the company ...
Abbott Laboratories' said on Monday it had received clearance to market the smallest version of its fastest-growing low-cost diabetes monitoring product in the European Union.
HealthDay News — Continuous glucose monitors (CGMs) do not accurately reflect blood sugar control in people without diabetes, according to a study published online Oct. 1 in Diabetes Technology & ...
Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback